Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma

J Hepatol. 2014 Jan;60(1):229-30. doi: 10.1016/j.jhep.2013.08.026. Epub 2013 Sep 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular / therapy*
  • Female
  • Humans
  • Liver Neoplasms / therapy*
  • Liver Transplantation*
  • Male
  • Neoplasm Recurrence, Local / therapy*
  • Niacinamide / analogs & derivatives*
  • Phenylurea Compounds / therapeutic use*

Substances

  • Phenylurea Compounds
  • Niacinamide